Canada markets closed

Entheon Biomedical Corp. (ENBI.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.2700-0.0100 (-3.57%)
At close: 2:12PM EDT
Full screen
Previous Close0.2800
Open0.2850
Bid0.2700 x N/A
Ask0.2850 x N/A
Day's Range0.2700 - 0.2850
52 Week Range0.2700 - 1.3500
Volume11,000
Avg. Volume77,486
Market Cap14.591M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.2170
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    Microdose Psychedelic Insights Announces Entheon Biomedical, Levitee Labs, and Women in Psychedelics to take centre stage at Psychedelic Capital: September 30, 2021

    Toronto, Ontario--(Newsfile Corp. - September 23, 2021) - Microdose Psychedelic Insights is proud to announce the upcoming Psychedelic Capital: September 2021 conference to be taking place on September 30, 2021, starting at 1:30pm EDT. The September edition will engage in discussions on Novel Psychedelic Molecules and Women in Psychedelics: Exploring the role of research and therapeutic experiences. The conference will play host to a number of corporate presentations, including Entheon Biomedica

  • Newsfile

    Leading DMT Companies to Take Stage at Molecular Masterclass: DMT Conference

    Get a free ticket to the event here: https://microdose.buzz/nwdmtToronto, Ontario--(Newsfile Corp. - September 1, 2021) - Microdose in partnership with Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1), a biotechnology company focused on developing psychedelic medicines to treat addiction, Small Pharma (TSXV: DMT) a neuropharmaceutical company taking a novel approach to depression drug development, Algernon Pharmaceuticals Inc. (CSE: AGN) a clinical-stage drug development company f

  • GlobeNewswire

    Microdose Psychedelic Insights Presents the Upcoming DMT Conference, a Deep Dive Into the Dynamic Field of DMT Therapeutics

    NEW YORK, Aug. 30, 2021 (GLOBE NEWSWIRE) -- via NetworkNewsWire -- Microdose Psychedelic Insights, a cutting-edge media company focused on promoting content, financial analysis, and engaging events designed to drive the psychedelics industry into the forefront of modern medicine, will be hosting the upcoming DMT Conference in an entirely virtual format Sept. 9-10, 2021. The virtual event will explore the potential of DMT (“Dimethyltryptamine”) at the intersection of drug development and safety,